$Roundhill Memory ETF(DRAM.US) continue adding to the position, no major issues seen for now.
Dermata Therapeutics
DRMA0.78109.61% ( -0.0830 )
Dermata Therapeutics (DRMA)
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The...
- Open
- 0.8331
- High
- 0.8497
- Low
- 0.7717
- Prev. Close
- 0.8640
- Volume
- 124.96K
- Turnover
- 100.82K
- Avg Price
- 0.8068
- Bid/Ask Ratio
- --
- Amplitude
- 9.03%
- 52wk High
- 4.6600
- Volume Ratio
- 2.30
- Turnover Ratio
- 4.26%
- 52wk Low
- 0.6032
- Float Mkt Cap
- 2.29M
- Market CapUSD
- 3.14M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -2.08
- EPSDynamic
- -2.39
- EPSStatic
- --
- BVPS
- 0.87
- P/B
- 0.90
- Circulating Supply
- 2.93M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 4.02M
- Min lot size
- 1
- Currency
- USD
Dermata Therapeutics Analyst Rating
View moreForecast & Rating
Aug 13, 2026Price forecast
$4.00412.16%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Movers ·
Dermata Therapeutics tumbles 8% in regular trading
- Global Report ·
QXO Digests USD 17B, and the Market's Odds and Ends Stir
- Global Report ·
Editas' Zero Crisis Sickle Cell Therapy Ignites Biotech's Quiet Comeback
- Weekly Review ·
Weekly Recap | Dermata Therapeutics -15.69%, Tome news fails to hold gains
- US Stock Market Update ·
Dermata Therapeutics soars 22% in regular trading on sector strength
- StockTitan ·
Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment | DRMA Stock News